Most Recent

The War Within

By | February 1, 2012

Unraveling the molecular causes of acute pancreatitis—a potentially deadly disease in which the pancreas essentially digests itself—is yielding clues to how it might be treated.

12 Comments

image: Resignations Over AIDS Denial

Resignations Over AIDS Denial

By | January 31, 2012

A member of an Italian journal’s editorial board resigns in protest of a paper denying the link between HIV and AIDs.

3 Comments

image: Opinion: Celebrities Pushing Drugs?

Opinion: Celebrities Pushing Drugs?

By | January 30, 2012

Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.

30 Comments

image: Chemicals Undermine Vaccines?

Chemicals Undermine Vaccines?

By | January 27, 2012

Perfluorinated compounds, a class of manufacturing chemicals, may be harming the immune system in a way that reduces the effectiveness of standard childhood vaccines.

0 Comments

image: A Peer Review Revolution?

A Peer Review Revolution?

By | January 24, 2012

A new social network provides a novel forum for science publishing and peer review.

9 Comments

image: Scanning the Psychedelic Brain

Scanning the Psychedelic Brain

By | January 23, 2012

Brain scans reveal the surprising secret of magic mushrooms’ hallucinogenic effect.

42 Comments

image: Poor Drug Trial Policing in India

Poor Drug Trial Policing in India

By | January 20, 2012

Government doctors involved in unethical trials are fined ineffectively small amounts of money.

0 Comments

image: Kiddy Meds

Kiddy Meds

By | January 19, 2012

Hundreds of new drugs for kids are in the horizon

3 Comments

image: Smart Drugs

Smart Drugs

By | January 18, 2012

Specialized tablets rigged with sensors monitor patients' medication use.

0 Comments

image: The Benefits of Coffee

The Benefits of Coffee

By | January 17, 2012

Researchers finally nail down why drinking coffee helps reduce the risk of developing Type 2 diabetes.

24 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham